Chargenrückruf – Ketasin 100 ad us. vet., Injektionslösung

Rückzug einzelner Chargen von Ketasin 100 ad us. vet., Injektionslösung, bis auf Stufe Detailhandel


Out-of-Stock – Lucentis, Injektionslösung zur intravitrealen Injektion in Fertigspritze

Befristete Bewilligung zum Vertrieb in englischer Aufmachung


DHPC – Haemocomplettan P (Fibrinogen aus Humanplasma)

Vorsichtsmassnahme: geänderte Lagertemperatur


HPC – Iberogast® Tinktur

Risiko von Leberschädigungen: weitere Anpassung der Arzneimittelinformation


Out-of-Stock – Isuprel®, Injektionslösung (s.c.) / Konzentrat zur Herstellung einer Infusionslösung (i.v.)

Befristete Bewilligung zum Vertrieb in französischer Aufmachung

In focus



Therapeutic Products Legislation update

The modifications following the ordinary revision of the TPA and its right of enforcement will enter into force on 1 January 2019

Direct links

Stay up to date

Incident reporting


Reporting undesirable effects

Medical devices

Reporting incidents & FSCAs



Swissmedic Vigilance News Edition 21

In this edition:

  • Isotretinoin and DOAC – Updates
  • Confusion between amphotericin B formulations
  • Guest articles: RPVC Zurich and RPVC Ticino
  • Quality Assurance in Transfusion Practice
  • Statistical Review 2017


What are the tasks of Swissmedic in the area of medical devices?

What is a medical device? How do medical devices come onto the market? How do you recognise a medical device? Based on examples, our videos answer these and a number of other questions.

Medical devices: List of Field Safety Corrective Actions (FSCA) and recalls

Swissmedic monitors all safety measures and recalls for medical devices that are manufactured or marketed in Switzerland.

Swissmedic, Swiss Agency for Therapeutic Products


Swissmedic – for therapeutic products you can trust

Swissmedic is the Swiss authority responsible for the authorisation and supervision of therapeutic products. Swissmedic's activities are based on the Law on Therapeutic Products.

For further information...